ImmunoVec
Company Details
Status: Private
Employees: 11-50
Location:
los angeles, california, united states
Type:
sample
Technology:
sample
About: ImmunoVec is a biotechnology company based in Santa Monica, California, founded in 2019. The company specializes in developing gene therapy treatments for terminal genetic diseases that affect the immune system, particularly those related to the hematopoietic system, which includes blood and bone marrow disorders.
ImmunoVec focuses on modifying or replacing genes to treat conditions such as hemic and lymphatic diseases. Their work targets specific genes like CYBB and CD34, aiming to provide life-saving therapies for patients with these genetic disorders. The company has raised $4.3 million in funding and has filed a patent application related to enhancers and vectors, indicating its commitment to advancing gene therapy technologies.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
ImmunoVec | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.